; and (2) not later than 3 years after the date of enactment of this Act, issue updated guidance for determining eligibility of donors of human cell and tissue products to comply with part 1271 of title 21, Code of Federal Regulations (or successor regulations), including compliance in determining donor eligibility in accordance with subpart C of part 1271 of title 21, Code of Federal Regulations (or successor regulations).